The literature article entitled, "verification of the australian orthopaedic association national joint replacement registry using a surgeon's database" written by bob jang, nichola a walsh, and warwick jm bruce published by journal of orthopaedic surgery 2013;21(3):347-50 published december 2013 was reviewed.The article's purpose was to report on verification or any discrepancies between a surgeon's database and the australian orthopaedic association national joint replacement registry.Although the article focuses on data entry discrepancies, it is noted that the database was specifically of patients that were revised who had depuy products initially implanted and reasons for revision were provided.Data was compiled from 231 primary tha on 217 patients receiving implants between 2002 and 2005.Depuy products utilized: corail stem, pinnacle cup, asr cup or duraloc, ceramic & poly liners adverse events (reference table on page 349): revisions for: cup loosening, osteolysis (mention of poly wear), infection, ceramic liner fracture, dislocation, poly wear, fractured stem.It is noted that each type of product has been explanted for one or more reasons in the revision procedures.The article does not provide adequate information to determine accurate quantities.
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.A worldwide lot specific complaint database search, or device history record (dhr) review was not possible because the required lot code(s) was not provided.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Corrective action was not indicated.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|